Fast Five Quiz: Acquired Haemophilia Management

Emmanuel C. Besa, MD

Disclosures

December 17, 2020

Acquired haemophilia is a rare but serious bleeding disorder caused by the spontaneous formation of autoantibodies directed against plasma coagulation factors, most often factor VIII (FVIII).

Management of acquired haemophilia involves curbing acute bleeding episodes, stifling the inhibitor activity and, when applicable, managing the underlying condition that triggered autoantibody formation. Because many patients with acquired haemophilia are elderly and have comorbid conditions, clinical decisions must be individualized. Both haemostatic and immunosuppressive therapy entail considerable risks and must be closely monitored.

How much do you know about the management of acquired haemophilia? Test your knowledge with this quick quiz.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....